Project Grant R25CA314973
Award Date 8/6/26
Completion Date 7/31/31
Dollars Obligated $316K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New Haven, CT 06511, USA
Similar Awards
- The National Cancer Institute awarded Yale University $100,228 on December 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support research training and biomedical career development in cancer research. Yale will conduct basic research on the regulation of membrane-chromatin interactions during mitotic nuclear formation and their role in cancer cell survival. The project investigates how endoplasmic reticulum membranes and LEM-domain proteins, including LEMD2 and emerin,...
- The National Cancer Institute awarded the Sloan-Kettering Institute for Cancer Research $252,023 on September 3, 2026, under the Cancer Research Manpower program (CFDA 93.398) to adapt an evidence-based goals-of-care communication intervention for adolescent and young adult cancer patients (ages 15–39). The project addresses poor end-of-life outcomes in this population, including high rates of futile aggressive care interventions in the final month of life and low hospice enrollment. Current...
- The National Cancer Institute awarded Yale University $100,228 on December 15, 2026, under the Cancer Research Manpower program (CFDA 93.398) to conduct observational studies on immune checkpoint inhibitor utilization, outcomes, and costs in advanced non-small cell lung cancer patients with preexisting autoimmune diseases. The research generates population-based evidence through three aims using real-world insurance claims data. Aim 1 analyzes MarketScan research databases to evaluate the...
- The National Cancer Institute awarded the Beckman Research Institute of the City of Hope $162,000 on August 11, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and pilot a self-directed e-learning delivery model for clinical cancer genomics education. The recipient will convert selected core recorded didactic modules from its established Intensive Course in Clinical Cancer Genomics into a self-directed e-learning course bundle using theoretically grounded...
- The National Cancer Institute awarded Yale University $130,490 on June 1, 2026, to support research on cellular and molecular mechanisms of early-onset colorectal cancer under the Cancer Research Manpower program (CFDA 93.398). The award is a Project Grant with a period of performance through May 31, 2028, and work is performed in New Haven, Connecticut. The Cancer Research Manpower program provides biomedical training opportunities for individuals pursuing careers in basic, clinical, and...
- The National Cancer Institute awarded The Trustees of Columbia University in the City of New York $140,364 on August 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support the K99 phase of research developing cancer survivor hospitalization risk assessment through multimodal analysis of care manager–patient communications in managed long-term care settings. The project, "The CHAMP Study: Cancer Survivor Hospitalization Risk Assessment Through Multimodal Patient-Care...
- The National Cancer Institute awarded $269,597 to the Beckman Research Institute of The City of Hope on August 10, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and deliver clinical trials nursing education. The recipient will create a curriculum to train oncology clinical trials nurses in quality care for patients enrolled in cancer treatment trials, deliver the curriculum through five national in-person courses and virtual offerings to competitively selected...
- The National Cancer Institute awarded Cold Spring Harbor Laboratory $105,020 on August 15, 2026, under the Cancer Research Manpower program (CFDA 93.398) to continue a seven-day intensive summer course on pancreatic cancer at the Banbury Center in Cold Spring Harbor, New York. The course serves medical and graduate students, postdoctoral fellows, and established investigators with a comprehensive curriculum covering organ anatomy and physiology, clinical diagnosis and treatment, molecular...
- The National Cancer Institute awarded Yale University $226,884 under the Cancer Research Manpower program (CFDA 93.398) on January 16, 2026, to support research training in cancer science. The award funds investigation into the role of aberrant m5C mRNA modification in translation initiation and cancer, with the recipient conducting screening of approximately 35,000 human endogenous 5′-untranslated region sequences from multiple tissues to identify m5C installation targets by NSUN2 and NSUN6...
- The National Cancer Institute awarded Weill Medical College of Cornell University a $1,053,426 cooperative agreement on March 20, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to establish the AYA Cohort to Enhance Survivorship in NYC (ACES-NYC), a prospective cohort enrolling and following 2,000 adolescent and young adult cancer survivors treated at three New York City cancer centers—Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and Columbia...